BioWorld-International-2010-08-18
New Agent Boosts Prospects for Photodynamic Therapy
PregLem In-Licenses Merck Serona's Jun Kinase Inhibitor
PregLem SA is in-licensing an oral, preclinical Jun kinase inhibitor, bentamapimod (AS602801), from Merck Serono SA, for prevention of postsurgical abdominal adhesions and endometriosis in patients. (BioWorld International)

